Nathan Jorgensen, Ph.D., M.B.A.
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Nathan Jorgensen, Ph.D., M.B.A.
Nathan Jorgensen, Ph.D., M.B.A. is recorded as CFO at Voyager Therapeutics, Inc. (VYGR). Voyager Therapeutics, Inc. reported in an 8-K filed June 13, 2024 that Nathan Jorgensen, Ph.D., M.B.A. was appointed Chief Financial Officer, principal financial officer, and principal accounting officer, effective July 8, 2024.
“On June 5, 2024, the board of directors of the Company (the "Board") authorized and approved the appointment of Dr. Jorgensen as Chief Financial Officer, principal financial officer, and principal accounting officer of the Company, effective upon the Jorgensen Commencement Date”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2024-07-08–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Voyager Therapeutics, Inc.
Other people whose current roles at this company are on record from its filings.
- Alfred Sandrock CEO, Board Member
- Alfred Sandrock, M.D., Ph.D. CEO, Board Member
- Michael Higgins CEO, Board Member
- Peter P. Pfreundschuh CFO
- Robin Swartz CFO, COO
- Glenn Pierce, M.D., Ph.D. CTO, Board Member
- Gregory Shiferman General Counsel
- Amy Quinlan Chief Accounting Officer
- Julie Burek Chief Accounting Officer
- Nathan Jorgensen Chief Accounting Officer
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.